August 15th, 2019
RLS Global AB Interim Report Q2, 2019
read more…
Settlement with Karin Bergqvist
Read moreRLS Global AB (PUBL) - Annual Report 2018
Read moreGothenburg, Sweden, April 10th, 2019 – RLS Global AB announces that ChloraSolv, its wound care product targeting diabetic foot ulcers, has successfully obtained a CE marking based on confirmation from Lloyd’s Register, acting as Notified Body, and is therefore cleared in 32 European countries for commercialization.
Read moreIntensified work with ChloraSolv.
Read moreRLS Global is a Swedish MedTech company based in Gothenburg, founded in 1996. Through our advanced and unique Buffered Hypochlorite based Technology Platform we focus on developing products based on Gentle methods for Minimally Invasive Treatment.
RLS Global AB
Neongatan 5
SE 431 53 Mölndal
Sweden
Customer Services & Orders:
+46 31 780 68 20
customer@rlsglobal.se
Office
+46 31 780 68 20
customer@rlsglobal.se
I am text block. Click edit button to change this text. Lorem ipsum dolor sit amet, consectetur adipiscing elit. Ut elit tellus, luctus nec ullamcorper mattis, pulvinar dapibus leo. I am text block. Click edit button to change this text. Lorem ipsum dolor sit amet, consectetur adipiscing elit. Ut elit tellus, luctus nec ullamcorper mattis, pulvinar dapibus leo.
I am text block. Click edit button to change this text. Lorem ipsum dolor sit amet, consectetur adipiscing elit. Ut elit tellus, luctus nec ullamcorper mattis, pulvinar dapibus leo. I am text block. Click edit button to change this text. Lorem ipsum dolor sit amet, consectetur adipiscing elit. Ut elit tellus, luctus nec ullamcorper mattis, pulvinar dapibus leo.
I am text block. Click edit button to change this text. Lorem ipsum dolor sit amet, consectetur adipiscing elit. Ut elit tellus, luctus nec ullamcorper mattis, pulvinar dapibus leo. I am text block. Click edit button to change this text. Lorem ipsum dolor sit amet, consectetur adipiscing elit. Ut elit tellus, luctus nec ullamcorper mattis, pulvinar dapibus leo.
I am text block. Click edit button to change this text. Lorem ipsum dolor sit amet, consectetur adipiscing elit. Ut elit tellus, luctus nec ullamcorper mattis, pulvinar dapibus leo. I am text block. Click edit button to change this text. Lorem ipsum dolor sit amet, consectetur adipiscing elit. Ut elit tellus, luctus nec ullamcorper mattis, pulvinar dapibus leo.
How does it work?
Using ChloraSolv
ChloraSolv consists of two solutions provided in a double syringe. The solutions are mixed to form a gel at the time of use. The gel is applied on the wound bed and allowed to act for 2 minutes to soften the devitalized tissue. A blunt instrument is then used to help in the mechanical removal devitalized tissue from the application site. Finish the procedure with a second application of the gel directly onto the wound area to completely clean the wound bed.
ChloraSolv – a valuable addition in the treatment of infected diabetic foot ulcers providing non-surgical debridement
We use cookies to help us deliver our services and provide personalised experiences. By using this website, you agree to our use of cookies.